Rifampicin as treatment for pruritus in malignant cholestasis: an example of an improper indication for anti-infective drugs.
Castagnola
E
E
Viscoli
C
C
D000904:Antibiotics, Antitubercular / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002779:Cholestasis / Q000150:complications*; D004352:Drug Resistance, Microbial; D006801:Humans; D016867:Immunocompromised Host; D009369:Neoplasms / Q000150:complications; D011537:Pruritus / Q000188:drug therapy* / Q000209:etiology; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000904:Antibiotics, Antitubercular; D012293:Rifampin